AcelRx Pharmaceuticals Inc ACRX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:56 PM EDT
0.21quote price arrow up+0.03 (+14.44%)
Volume
23,971
Close
0.18quote price arrow down-0.0194 (-9.7292%)
Volume
908,789
52 week range
0.16 - 1.55
Loading...
  • Open0.2035
  • Day High0.21
  • Day Low0.18
  • Prev Close0.1994
  • 52 Week High1.55
  • 52 Week High Date07/14/21
  • 52 Week Low0.16
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap26.48M
  • Shares Out147.12M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-67.87

KEY STATS

  • Open0.2035
  • Day High0.21
  • Day Low0.18
  • Prev Close0.1994
  • 52 Week High1.55
  • 52 Week High Date07/14/21
  • 52 Week Low0.16
  • 52 Week Low Date05/12/22
  • Market Cap26.48M
  • Shares Out147.12M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-67.87

RATIOS/PROFITABILITY

  • EPS (TTM)-0.27
  • P/E (TTM)-0.66
  • Fwd P/E (NTM)-1.06
  • EBITDA (TTM)-33.544M
  • ROE (TTM)-2,520.57%
  • Revenue (TTM)2.75M
  • Gross Margin (TTM)-27.21%
  • Net Margin (TTM)-1,266.53%
  • Debt To Equity (MRQ)-30.97%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AcelRx Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio of products and product candidates consists of sufentanil sublingual products and product candidates, pre-filled syringe product candidates and nafamostat mesylate product candidates. Its sufentanil sublingual products include DSUVIA, DZUVEO and Zalviso, which are focused on the...
Adrian Adams
Independent Chairman of the Board
Vincent Angotti
Chief Executive Officer, Director
Raffi Asadorian
Chief Financial Officer
Address
25821 Industrial Boulevard
351 GALVESTON DRIVE
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
ACUR
Acura Pharmaceuticals Inc
0.48UNCHUNCH
NAVB
Navidea Biopharmaceuticals Inc
0.65-0.09-12.1622%
NOVN
Novan Inc
2.36+0.07+3.06%
CYTH
Cyclo Therapeutics Inc
2.10-0.10-4.55%
KALA
Kala Pharmaceuticals Inc
0.3614-0.0192-5.0447%